Respiratory & Immunology电竞外围投注app

lol官网竞猜

lol官网竞猜

lol官网竞猜


lol官网竞猜

电竞外围投注app




电竞外围投注app


电竞外围投注app


电竞外围投注app


lol官网竞猜

Phase III/Reg. refers to assets that are in Phase III or that have been submitted for regulatory approval and may include assets that are now launched in one or more major markets.


lol官网竞猜

Phase I

电竞外围投注app

  • AZD0284 psoriasis/respiratory
  • AZD0449 asthma
  • AZD1402 asthma
  • AZD5634 cystic fibrosis
  • AZD8154 asthma
  • MEDI5117 China rheumatoid arthritis

Phase II

电竞外围投注app

  • abediterol asthma/chronic obstructive pulmonary disease
  • anifrolumab lupus nephritis
  • anifrolumab systemic lupus erythematosus (subcutaneous)
  • AZD7986 chronic obstructive pulmonary disease
  • AZD9567 rheumatoid arthritis/respiratory
  • MEDI3506 chronic obstructive pulmonary disease and atopic dermatitis
  • navafenterol (AZD8871) chronic obstructive pulmonary disease
  • tezepelumab atopic dermatitis
  • tezepelumab chronic obstructive pulmonary disease
  • velsecorat (AZD7594) asthma/chronic obstructive pulmonary disease

Phase III

电竞外围投注app

  • anifrolumab TULIP systemic lupus erythematosus
  • Bevespi Aerosphere (PT003) chronic obstructive pulmonary disease
  • Breztri Aerosphere (PT010) chronic obstructive pulmonary disease
  • Fasenra CALIMA SIROCCO ZONDA BISE BORA GREGALE MIRACLE severe uncontrolled asthma
  • nirsevimab passive RSV immunisation
  • PT027 asthma
  • tezepelumab NAVIGATOR SOURCE severe uncontrolled asthma

LCM Projects

电竞外围投注app

  • Breztri (PT010) asthma
  • Duaklir Genuair chronic obstructive pulmonary disease
  • Fasenra MANDARA eosinophilic granulomatosis with polyangiitis
  • Fasenra OSTRO ORCHID (Japan/China) nasal polyposis
  • Fasenra RESOLUTE chronic obstructive pulmonary disease
  • Symbicort SYGMA as-needed use in mild asthma



电竞外围投注app


lol官网竞猜

电竞外围投注app


Accolate, Accoleit, Vanticon电竞外围投注app

zafirlukast

Bevespi Aerosphere电竞外围投注app

glycopyrronium/formoterol fumarate

Breztri Aerosphere电竞外围投注app

budesonide/glycopyrronium/formoterol fumarate

Bricanyl Respules电竞外围投注app

terbutaline

Bricanyl Turbuhaler电竞外围投注app

terbutaline in a dry powder inhaler

Daliresp/Daxas电竞外围投注app

roflumilast

Duaklir Genuair电竞外围投注app

aclidinium/formoterol

Eklira Genuair/Tudorza/Bretaris电竞外围投注app

aclidinium, a LAMA

Fasenra电竞外围投注app

benralizumab

Oxis Turbuhaler电竞外围投注app

Oxis Turbuhaler

Pulmicort Respules电竞外围投注app

budesonide inhalation suspension

Pulmicort Turbuhaler电竞外围投注app

budesonide

Rhinocort电竞外围投注app

budesonide

Symbicort pMDI电竞外围投注app

budesonide/formoterol

Symbicort Turbuhaler电竞外围投注app

budesonide/formoterol


电竞外围投注app



Veeva ID: Z4-23796

Date of next review: April 2022